Shares of United Natural Foods, Inc. (NYSE: UNFI) were up 1.1% on Wednesday. The stock has gained 28% over the past 12 months and 17% over the past three months. The company delivered better-than-expected results for the third quarter of 2022 a day ago and raised its guidance for the full year. Here’s a look at its expectations for both the near and long term:
Sales
In Q3, UNFI’s sales grew 9.2% to $7.2 billion. The top line growth was driven by sales gains from both new and existing customers as well as inflation. The company’s success in selling more to existing customers, combined with new customer wins, helped yield volume gains of around 2.5% in the quarter.
Although restrictions have eased for the most part, people still continue to work from home or are opting for hybrid work models. This, coupled with the tightening of household budgets due to high food inflation, are expected to continue driving strong food-at-home sales.
UNFI’s sales growth in the quarter was broad-based across all divisions. Both Independent Retailers and Supernatural witnessed growth of more than 14%, which was the highest. Sales from Chains grew 5.2% while Retail sales rose 2% in the quarter.
Cross-selling gains with existing customers added an incremental $95 million in revenue during the quarter. UNFI remains on track to achieve nearly $1 billion in cross-selling revenue in fiscal year 2022.
For FY2022, United Natural raised its sales guidance to a range of $28.8-29.1 billion from the previous range of $27.8-28.3 billion. The current outlook represents a growth of 7% at the midpoint.
Profitability
In Q3, UNFI’s net income increased 39.6% to $67 million and EPS was up 37.5% to $1.10. Adjusted EPS rose 10% to $1.10. Adjusted gross margin rate rose to 15% from 14.7% in the year-ago period, helped by improvements in the Wholesale segment margin rate, including the impact of inflation. Adjusted EBITDA rose 6% YoY to $196 million.
UNFI raised its earnings guidance for fiscal year 2022 and now expects net income to range between $230-245 million, representing a growth of 59% at the midpoint. This compares to the previous outlook of $221-243 million.
GAAP EPS is projected to be $3.75-4.00, up 56% YoY, while adjusted EPS is expected to be $4.65-4.90, up 14%. This compares to the previous guidance ranges of $3.60-3.90 for GAAP EPS and $4.20-4.50 for adjusted EPS. Adjusted EBITDA is estimated to range between $810-830 million compared to the prior range of $785-815 million.
Long-term targets
Looking ahead to FY2024, UNFI expects average annual growth rates for net sales to be 3-5%, adjusted EPS to be 12-18% and adjusted EBITDA to be 6-10%. The company estimates its targets for adjusted EBITDA to be at least $950 million and adjusted EPS to be at least $6.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on